Dag Nyholm

5.8k total citations
135 papers, 3.9k citations indexed

About

Dag Nyholm is a scholar working on Neurology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dag Nyholm has authored 135 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Neurology, 25 papers in Epidemiology and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dag Nyholm's work include Parkinson's Disease Mechanisms and Treatments (97 papers), Neurological disorders and treatments (89 papers) and Restless Legs Syndrome Research (25 papers). Dag Nyholm is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (97 papers), Neurological disorders and treatments (89 papers) and Restless Legs Syndrome Research (25 papers). Dag Nyholm collaborates with scholars based in Sweden, United States and Denmark. Dag Nyholm's co-authors include Sten‐Magnus Aquilonius, Håkan Askmark, Hans Lennernäs, Marina Senek, Anders Johansson, Jerker Westin, Mevludin Memedi, Nil Dizdar, Jonas Bergquist and Rasmus Jansson‐Löfmark and has published in prestigious journals such as NeuroImage, Brain and Neurology.

In The Last Decade

Dag Nyholm

126 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dag Nyholm Sweden 35 3.2k 685 664 440 383 135 3.9k
Peter Kempster Australia 27 3.0k 0.9× 772 1.1× 363 0.5× 388 0.9× 398 1.0× 87 3.8k
Kelvin L. Chou United States 32 2.5k 0.8× 642 0.9× 333 0.5× 438 1.0× 625 1.6× 123 3.2k
Allison W. Willis United States 30 2.3k 0.7× 552 0.8× 417 0.6× 400 0.9× 643 1.7× 137 4.0k
Donald G. Grosset United Kingdom 46 4.1k 1.3× 984 1.4× 1.4k 2.0× 552 1.3× 572 1.5× 168 6.4k
Alastair J. Noyce United Kingdom 36 2.9k 0.9× 766 1.1× 405 0.6× 418 0.9× 436 1.1× 146 4.5k
Teus van Laar Netherlands 39 4.2k 1.3× 1.2k 1.8× 314 0.5× 904 2.1× 716 1.9× 183 5.6k
Inga Liepelt‐Scarfone Germany 23 2.2k 0.7× 396 0.6× 323 0.5× 503 1.1× 568 1.5× 100 3.0k
Hubert H. Fernandez United States 43 4.6k 1.4× 1.5k 2.2× 496 0.7× 622 1.4× 867 2.3× 225 6.0k
Carsten Buhmann Germany 32 2.2k 0.7× 889 1.3× 230 0.3× 505 1.1× 316 0.8× 146 3.7k
Heinz Reichmann Germany 39 3.2k 1.0× 1.0k 1.5× 698 1.1× 551 1.3× 464 1.2× 199 5.8k

Countries citing papers authored by Dag Nyholm

Since Specialization
Citations

This map shows the geographic impact of Dag Nyholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dag Nyholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dag Nyholm more than expected).

Fields of papers citing papers by Dag Nyholm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dag Nyholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dag Nyholm. The network helps show where Dag Nyholm may publish in the future.

Co-authorship network of co-authors of Dag Nyholm

This figure shows the co-authorship network connecting the top 25 collaborators of Dag Nyholm. A scholar is included among the top collaborators of Dag Nyholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dag Nyholm. Dag Nyholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nyholm, Dag, et al.. (2025). Therapies for Advanced Parkinson’s Disease in Sweden: A Cost-Effectiveness Analysis Using Real-World Data. Neurology and Therapy. 14(3). 801–812.
2.
Ekblom, Maria, Dag Nyholm, Lena Zetterberg, Katarina Laurell, & Johan Virhammar. (2025). Blinded gait assessment in idiopathic normal pressure hydrocephalus: reliability and correlation with clinical and patient-reported outcomes. Fluids and Barriers of the CNS. 22(1). 91–91.
3.
Jenner, Peter & Dag Nyholm. (2025). COMT inhibition with entacapone for patients with Parkinson’s disease and motor complications: the novelty of continuous infusion. Journal of Neural Transmission. 133(2). 361–375.
4.
Zetterberg, Lena, et al.. (2024). “I’m still the person I am. Not the body it has become.” An active but challenging life with cervical dystonia. Physiotherapy Theory and Practice. 41(4). 763–771. 2 indexed citations
5.
Bergquist, Filip, M. Ehrnebo, Dag Nyholm, et al.. (2024). Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion. Movement Disorders Clinical Practice. 11(9). 1095–1102. 3 indexed citations
6.
Nyholm, Dag, et al.. (2024). A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease. Movement Disorders Clinical Practice. 11(12). 1609–1612. 3 indexed citations
7.
Bergquist, Filip, Per Odin, Anders Johansson, et al.. (2024). Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease. European Journal of Neurology. 32(1). e16582–e16582. 3 indexed citations
8.
Bergquist, Filip, M. Ehrnebo, Dag Nyholm, et al.. (2022). Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease. Neurology. 99(10). e965–e976. 15 indexed citations
9.
Johansson, Anders, et al.. (2021). Personalized Medicine Approach in Treating Parkinson’s Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice. Journal of Personalized Medicine. 11(8). 720–720. 13 indexed citations
10.
Nyholm, Dag, et al.. (2020). Real-Life Use of Levodopa/Carbidopa Intestinal Gel in Parkinson’s Disease According to Analysis of Pump Data. Journal of Parkinson s Disease. 10(4). 1529–1534. 6 indexed citations
11.
Buvarp, Dongni, Ilias Thomas, Anders Ericsson, et al.. (2019). Evaluation of a sensor algorithm for motor state rating in Parkinson's disease. Parkinsonism & Related Disorders. 64. 112–117. 5 indexed citations
12.
Senek, Marina, Sten‐Magnus Aquilonius, Håkan Askmark, et al.. (2017). Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment. European Journal of Clinical Pharmacology. 73(5). 563–571. 38 indexed citations
13.
Thomas, Ilias, Jerker Westin, Moudud Alam, et al.. (2017). A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States. IEEE Journal of Biomedical and Health Informatics. 22(5). 1341–1349. 40 indexed citations
14.
Memedi, Mevludin, Dag Nyholm, Anders Johansson, et al.. (2015). Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease. IEEE Journal of Biomedical and Health Informatics. 19(6). 1829–1834. 13 indexed citations
15.
Memedi, Mevludin, Dag Nyholm, Anders Johansson, et al.. (2013). Self-reported symptoms and motor tests via telemetry in a 36-month levodopa-carbidopa intestinal gel infusion trial. Dalarna University College Electronic Archive. 2 indexed citations
16.
Nyholm, Dag. (2011). Pharmacotherapy for Parkinson's Disease - Observations and Innovations. Europe PMC (PubMed Central). 243. 105271–105271. 1 indexed citations
17.
Westin, Jerker, Mark Dougherty, Dag Nyholm, & Torgny Groth. (2006). A home environment test battery for status assessment in patients with motor fluctuations. European Journal of Neurology. 13. 213–214. 6 indexed citations
18.
Westin, Jerker, Mobyen Uddin Ahmed, Dag Nyholm, Mark Dougherty, & Torgny Groth. (2006). A fuzzy rule-based decision support system for Duodopa treatment in Parkinson's disease. European Journal of Neurology. 13. 214–214. 1 indexed citations
19.
Nyholm, Dag, et al.. (2005). Prevalence of multiple sclerosis in a residential area bordering an oil refinery. Neurology. 64(2). 223–223. 1 indexed citations
20.
Kristiansen, Ivar Sønbø, et al.. (2005). The cost-effectiveness of continuous duodenal delivery of levodopa (Duodopa®) in patients with severe Parkinson's disease (abstract). Movement Disorders. 20. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Kempster Breakdown of academic impact, for papers by Kelvin L. Chou Breakdown of academic impact, for papers by Allison W. Willis Breakdown of academic impact, for papers by Donald G. Grosset Breakdown of academic impact, for papers by Alastair J. Noyce Breakdown of academic impact, for papers by Teus van Laar Breakdown of academic impact, for papers by Inga Liepelt‐Scarfone Breakdown of academic impact, for papers by Hubert H. Fernandez Breakdown of academic impact, for papers by Carsten Buhmann Breakdown of academic impact, for papers by Heinz Reichmann
Rankless by CCL
2026